SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, ...

South Sudan, in partnership with United Nations agencies, on Tuesday launched two vaccines to prevent pneumonia and severe ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its ...

SK bioscience successfully developed Korea's first 13-valent pneumococcal conjugate vaccine, SKYPneumo, in 2016. However, due to the ongoing patent dispute with Pfizer, the company has been ...

Vaccine and biotech company SK bioscience announced Wednesday that it the Supreme Court of Korea has ruled in its favor in a patent infringement lawsuit filed by large ...

South Korean vaccine maker SK Bioscience has secured a final court victory over US pharma major Pfizer in a long-running ...

Pneumococcal meningitis was associated with a case-fatality rate of almost 30% in children with sickle cell disease, a study ...

SEOUL, May 21 (Yonhap) -- SK bioscience Co., a biotech arm of South Korea's SK Group, said Wednesday it has won a patent ...